C. Iliescu

Peter Y. Kim, K. Toutouzas, R. Smalling, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Evaluation and Management of Cardiac Tumors

Peter Y. Kim, G. Gladish, J. Durand, 2018, Current Treatment Options in Cardiovascular Medicine.

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment

J. Durand, J. Lopez-Mattei, N. Palaskas, 2020, Journal of the American Heart Association.

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis

Peter Y. Kim, G. Gladish, J. Durand, 2018, Open Heart.

Editorial Commentary: Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.

Peter Y. Kim, J. Lopez-Mattei, P. Kim, 2019, Trends in cardiovascular medicine.

The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment

Peter Y. Kim, James C Yao, I. Gregoric, 2018, Oncology letters.

Multimodality imaging in carcinoid heart disease

Peter Y. Kim, G. Gladish, S. Yusuf, 2019, Open Heart.

Progressive and Reversible Conduction Disease With Checkpoint Inhibitors.

Shreyaskumar R Patel, N. Somaiah, J. Lopez-Mattei, 2017, The Canadian journal of cardiology.

Cancer treatment resumption in patients with new-generation drug-eluting stents.

Juhee Song, M. Cilingiroglu, M. Aziz, 2020, Coronary artery disease.

Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy

J. Durand, S. Subudhi, Bihong Zhao, 2021, European journal of heart failure.

Skip Soft Definitions and Focus on Hard Endpoints

J. Lopez-Mattei, N. Palaskas, C. Iliescu, 2019, JACC. CardioOncology.

Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.

Peter Y. Kim, J. Kobashigawa, J. Durand, 2020, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS).

C. Rochitte, R. Blankstein, M. Ferencik, 2022, Journal of cardiovascular computed tomography.

Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score

D. Monlezun, C. Iliescu, T. Aksamit, 2022, Medicina.

Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors.

Peter Y. Kim, A. Naing, D. Hong, 2019, The American journal of cardiology.

Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib

K. Gould, J. Lopez-Mattei, D. Balanescu, 2018, Cardiovascular Toxicology.

Cardiotoxicity: Cardiac Ischemia

R. Labianca, C. Iliescu, C. Lestuzzi, 2017 .

Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection.

D. McPherson, H. Safi, C. Iliescu, 2008, Texas Heart Institute journal.

Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients?

P. Vejpongsa, S. Yusuf, J. Lopez-Mattei, 2016, Journal of the American College of Cardiology.

Cardiovascular interventions in thrombocytopenic cancer patients.

J. Durand, M. Kroll, C. Iliescu, 2011, Texas Heart Institute journal.

Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy

Peter Y. Kim, J. Lopez-Mattei, R. Moudgil, 2017, European heart journal. Case reports.

TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients

Z. Iakobishvili, D. Monlezun, M. Ewer, 2020, Cardio-Oncology.

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.

W. William, S. Yusuf, Juhee Song, 2015, Journal of the American College of Cardiology.

Stress-Induced Cardiomyopathy in Cancer Patients.

Peter Y. Kim, P. Vejpongsa, M. Ewer, 2017, The American journal of cardiology.

Resolution of Myelofibrosis-Associated Pulmonary Arterial Hypertension following Allogeneic Hematopoietic Stem Cell Transplantation

L. Bashoura, S. Faiz, U. Popat, 2016, Pulmonary circulation.

Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis).

Peter Y. Kim, A. Zaman, C. Kwok, 2019, The American journal of cardiology.

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis

Amit R. Patel, Peter Y. Kim, G. Gladish, 2021, Frontiers in Cardiovascular Medicine.

Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy

Amit R. Patel, Peter Y. Kim, G. Gladish, 2021, Frontiers in Cardiovascular Medicine.

Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?

D. Mutlu, M. Cilingiroglu, K. Marmagkiolis, 2021, The Eurasian journal of medicine.

The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.

D. Monlezun, V. Verma, Bala Pushparaji, 2020, Critical reviews in oncology/hematology.

DIAGNOSTIC PERFORMANCE OF HIGH SENSITIVITY TROPONIN IN CANCER PATIENTS

J. Durand, J. Lopez-Mattei, N. Palaskas, 2019, Journal of the American College of Cardiology.

How to Diagnose and Manage QT Prolongation in Cancer Patients

Peter Y. Kim, J. Lopez-Mattei, P. Kim, 2021, JACC. CardioOncology.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Brian Walters, F. Clubb, J. Alroy, 2006, Nature Medicine.

Cancer therapeutic drug guide

J. Herrmann, T. Neilan, T. Eschenhagen, 2022, Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease.

NPGRJ_NM_1446 908..916

F. Clubb, J. Alroy, R. Yacobi, 2006 .

Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications

F. Triposkiadis, H. Boudoulas, K. Boudoulas, 2022, Cardiology.

D. Gomez, R. Howell, C. Pinnix, 2015, Future oncology.

Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: A case series

J. Nates, S. Tummala, C. Iliescu, 2022 .

Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue

C. Grines, K. Toutouzas, J. Herrmann, 2016, Circulation.

Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias.

Peter Y. Kim, E. Jahangir, E. Yang, 2020, Journal of immunotherapy and precision oncology.

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

L. Buja, J. Lopez-Mattei, K. Marmagkiolis, 2020, JACC. Case reports.

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.

D. Fischman, C. Kwok, M. Mamas, 2018, European heart journal.

OP-EHEA180786_online 1790..1801

D. Fischman, C. Kwok, M. Mamas, 2019 .

SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista)

C. Grines, K. Toutouzas, J. Herrmann, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Opportunities for improved cardiovascular disease prevention in oncology patients.

Peter Y. Kim, Arjun K. Ghosh, C. Manisty, 2020, Current opinion in cardiology.

Acute Coronary Syndrome in Patients with Cancer

J. Abe, S. Yusuf, Saamir A Hassan, 2018 .

Arterial Thrombosis in Patients with Cancer

J. Herrmann, B. Ziaeian, E. Yang, 2018, Current Treatment Options in Cardiovascular Medicine.

Ischemic Heart Disease: Special Considerations in Cardio-Oncology

Peter Y. Kim, F. Boccalandro, J. Lopez-Mattei, 2017, Current Treatment Options in Cardiovascular Medicine.

Prevalence of pulmonary hypertension in myelofibrosis

Peter Y. Kim, H. Grosu, S. Faiz, 2020, Annals of Hematology.

Management of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective

J. Durand, C. Iliescu, K. Marmagkiolis, 2017, Current Cardiology Reports.

Cancer as a Risk Factor for Cardiovascular Disease

K. Marmagkiolis, Saamir A Hassan, C. Iliescu, 2017, Current Oncology Reports.

Primary Percutaneous Coronary Interventions in Cancer Patients

K. Marmagkiolis, C. Iliescu, Despina Tsitlakidou, 2017 .

Percutaneous coronary intervention and in‐hospital outcomes in patients with leukemia: a nationwide analysis

M. Konopleva, M. Mohamed, M. Mamas, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule.

Peter Y. Kim, Z. Iakobishvili, I. Gregoric, 2020, International journal of cardiology.

Assessment of vascular patency and inflammation with intravascular optical coherence tomography in patients with superficial femoral artery disease treated with Zilver PTX stents.

T. Milner, M. Feldman, J. Dijkstra, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Applications of Cardiac Computed Tomography in the Cardio-Oncology Population

M. Budoff, M. Ferencik, J. Herrmann, 2019, Current Treatment Options in Oncology.

Differentiation of Cardiac Masses by Cardiac Magnetic Resonance Imaging

Peter Y. Kim, G. Gladish, J. Stojanovska, 2020, Current Cardiovascular Imaging Reports.

Radiation-Induced Vascular Disease—A State-of-the-Art Review

R. Virmani, C. Grines, K. Toutouzas, 2021, Frontiers in Cardiovascular Medicine.

Cardiac Interventional Procedures in Cardio-Oncology Patients.

Peter Y. Kim, M. Cilingiroglu, J. Lopez-Mattei, 2019, Cardiology clinics.

Interventional Cardiology in the Cancer Patient

K. Marmagkiolis, D. Balanescu, T. Donisan, 2019, Oncologic Critical Care.

Acute Coronary Syndrome, Thrombocytopenia, and Antiplatelet Therapy in Critically Ill Cancer Patients

K. Marmagkiolis, D. Balanescu, T. Donisan, 2019, Oncologic Critical Care.

Rate of Progression of Aortic Stenosis in Patients With Cancer

S. Yusuf, Juhee Song, Saamir A Hassan, 2021, Frontiers in Cardiovascular Medicine.

Cardiac amyloidosis

M. Qazilbash, J. Durand, S. Yusuf, 2014, Expert review of cardiovascular therapy.

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field

Peter Y. Kim, Victor Y Liu, J. Lopez-Mattei, 2018, Front. Cardiovasc. Med..

Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.

P. Douglas, J. Plana, M. Chen, 2015, Journal of the American College of Cardiology.

The role of cardiac MRI in cardio-oncology.

Peter Y. Kim, G. Gladish, J. Durand, 2017, Future cardiology.

Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity.

Peter Y. Kim, J. Durand, J. Lopez-Mattei, 2020, Advances in experimental medicine and biology.

Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations

Peter Y. Kim, M. Gulati, C. Kwok, 2020, International journal of clinical practice.

Coronary Stent Healing in Cancer Patients—An Optical Coherence Tomography Perspective

M. Feldman, H. Anderson, J. Dijkstra, 2021, Frontiers in Cardiovascular Medicine.

“Bringing on the light” in a complex clinical scenario: Optical coherence tomography–guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT‐OCT registry)

O. Rosales, P. Loyalka, E. Perin, 2017, American heart journal.

Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients

M. Mamas, D. Monlezun, J. Lopez-Mattei, 2021, Frontiers in Cardiovascular Medicine.

Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis

J. Durand, S. Yusuf, Juhee Song, 2023, Frontiers in Cardiovascular Medicine.

Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia

Juhee Song, M. Cilingiroglu, J. Lopez-Mattei, 2021, Frontiers in Cardiovascular Medicine.

Transpedal Access for the Management of Complex Peripheral Artery Disease.

D. Feldman, M. Montero-Baker, K. Marmagkiolis, 2017, The Journal of invasive cardiology.

Cardiovascular manifestations of Erdheim–Chester disease

Peter Y. Kim, S. Yusuf, J. Lopez-Mattei, 2018, Echocardiography.

SCAI expert consensus statement-executive summary evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory

C. Grines, K. Toutouzas, J. Herrmann, 2015 .

Acute coronary syndrome in patients with cancer

J. Abe, S. Yusuf, Saamir A Hassan, 2022, Expert review of cardiovascular therapy.

Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography

Peter Y. Kim, J. Durand, M. Kroll, 2020, Frontiers in Cardiovascular Medicine.

Impact of Cardiopulmonary Resuscitation on Survival in Cancer Patients

C. Gutierrez, D. Balanescu, T. Donisan, 2020, JACC. CardioOncology.

Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib

K. Gould, J. Lopez-Mattei, D. Balanescu, 2018, Cardiovascular Toxicology.

Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue

C. Grines, K. Toutouzas, J. Herrmann, 2016, Circulation.

Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature

J. Nates, S. Tummala, C. Iliescu, 2023, BMC Anesthesiology.

Primary Patency With Stenting Versus Balloon Angioplasty for Arteriovenous Graft Failure: A Systematic Review and Meta-Analysis.

K. Boudoulas, Akash Gupta, M. Cilingiroglu, 2019, The Journal of invasive cardiology.

Aspergillus endocarditis of the mitral valve with ventricular myocardial invasion, cerebral vasculitis, and intracranial mycotic aneurysm formation in a patient with hemophagocytic lymphohistiocytosis

Peter Y. Kim, J. Lopez-Mattei, C. Iliescu, 2018, Medical mycology case reports.

1262 Elevated serum TNF-α is a candidate prognostic biomarker for immune checkpoint inhibitor myocarditis

Abdelrahman A Ali, S. Yusuf, S. Subudhi, 2022, Regular and Young Investigator Award Abstracts.

Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes

J. Herrmann, E. Yang, P. Parwani, 2022, Reviews in cardiovascular medicine.

Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue".

J. Herrmann, E. Yang, K. Marmagkiolis, 2016, Circulation.

TAKOTSUBO CARDIOMYOPATHY IN CANCER PATIENTS: TRIGGERS, RECOVERY, AND RESUMPTION OF THERAPY

S. Yusuf, C. Iliescu, J. Banchs, 2015 .

Acute mitral regurgitation with and without acute heart failure

F. Triposkiadis, H. Boudoulas, K. Boudoulas, 2023, Heart Failure Reviews.